These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1570838)

  • 121. Prolonged neuromuscular blockade following succinylcholine administration to a patient with a reduced butyrylcholinesterase activity.
    Panhuizen IF; Snoeck MM; Levano S; Girard T
    Case Rep Med; 2010; 2010():472389. PubMed ID: 20589221
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.
    Ben Assayag E; Shenhar-Tsarfaty S; Ofek K; Soreq L; Bova I; Shopin L; Berg RM; Berliner S; Shapira I; Bornstein NM; Soreq H
    Mol Med; 2010; 16(7-8):278-86. PubMed ID: 20464061
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.
    Reitz C; Mayeux R
    J Alzheimers Dis; 2010; 19(1):229-51. PubMed ID: 20061642
    [TBL] [Abstract][Full Text] [Related]  

  • 124. BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia.
    Bizzarro A; Guglielmi V; Lomastro R; Valenza A; Lauria A; Marra C; Silveri MC; Tiziano FD; Brahe C; Masullo C
    J Neural Transm (Vienna); 2010 Mar; 117(3):377-83. PubMed ID: 20058037
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes.
    Searles Nielsen S; McKean-Cowdin R; Farin FM; Holly EA; Preston-Martin S; Mueller BA
    Environ Health Perspect; 2010 Jan; 118(1):144-9. PubMed ID: 20056567
    [TBL] [Abstract][Full Text] [Related]  

  • 126. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.
    Podoly E; Shalev DE; Shenhar-Tsarfaty S; Bennett ER; Ben Assayag E; Wilgus H; Livnah O; Soreq H
    J Biol Chem; 2009 Jun; 284(25):17170-17179. PubMed ID: 19383604
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis.
    Kamal MA; Qu X; Yu QS; Tweedie D; Holloway HW; Li Y; Tan Y; Greig NH
    J Neural Transm (Vienna); 2008 Jun; 115(6):889-98. PubMed ID: 18235987
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Interaction between estrogen receptor-alpha and butyrylcholinesterase genes modulates Alzheimer's disease risk.
    Combarros O; Riancho JA; Arozamena J; Mateo I; Llorca J; Infante J; Sánchez-Juan P; Zarrabeitia MT; Berciano J
    J Neurol; 2007 Sep; 254(9):1290-2. PubMed ID: 17410321
    [No Abstract]   [Full Text] [Related]  

  • 129. Comparison of cognitive functions between people with silent and wild-type butyrylcholinesterase.
    Manoharan I; Kuznetsova A; Fisk JD; Boopathy R; Lockridge O; Darvesh S
    J Neural Transm (Vienna); 2007 Jul; 114(7):939-45. PubMed ID: 17318303
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Production of the butyrylcholinesterase knockout mouse.
    Li B; Duysen EG; Saunders TL; Lockridge O
    J Mol Neurosci; 2006; 30(1-2):193-5. PubMed ID: 17192674
    [TBL] [Abstract][Full Text] [Related]  

  • 131. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
    Holmes C; Ballard C; Lehmann D; David Smith A; Beaumont H; Day IN; Nadeem Khan M; Lovestone S; McCulley M; Morris CM; Munoz DG; O'Brien K; Russ C; Del Ser T; Warden D
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):640-3. PubMed ID: 15834019
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion.
    Johansen A; Nielsen EM; Andersen G; Hamid YH; Jensen DP; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabetologia; 2004 Aug; 47(8):1437-41. PubMed ID: 15258737
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Frequency and enzyme activity of the butyrylcholinesterase K-variant in a Turkish population.
    Babaoglu MO; Ocal T; Bayar B; Kayaalp SO; Bozkurt A
    Eur J Clin Pharmacol; 2004 Feb; 59(12):875-7. PubMed ID: 14735258
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
    McIlroy SP; Crawford VL; Dynan KB; McGleenon BM; Vahidassr MD; Lawson JT; Passmore AP
    J Med Genet; 2000 Mar; 37(3):182-5. PubMed ID: 10699053
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Genetic risk factors in Alzheimer's disease.
    Tilley L; Morgan K; Kalsheker N
    Mol Pathol; 1998 Dec; 51(6):293-304. PubMed ID: 10193509
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.
    Primo-Parmo SL; Bartels CF; Wiersema B; van der Spek AF; Innis JW; La Du BN
    Am J Hum Genet; 1996 Jan; 58(1):52-64. PubMed ID: 8554068
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism.
    Bartels CF; Zelinski T; Lockridge O
    Am J Hum Genet; 1993 May; 52(5):928-36. PubMed ID: 8488842
    [TBL] [Abstract][Full Text] [Related]  

  • 139. A new detection method for the K variant of butyrylcholinesterase based on PCR primer introduced restriction analysis (PCR-PIRA).
    Shibuta K; Abe M; Suzuki T
    J Med Genet; 1994 Jul; 31(7):576-9. PubMed ID: 7966197
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Cholinesterase variants: rapid characterisation by PCR/SSCP and evidence for molecular homogeneity.
    Höhler T; Hundt M; Rittner C; Schneider PM; Meyer zum Büschenfelde KH
    J Med Genet; 1995 Feb; 32(2):109-12. PubMed ID: 7760318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.